Elevation of ceramide and activation of secretory acid sphingomyelinase in patients with acute coronary syndromes

Coronary Artery Disease

Volumn 25, Issue 3, 2014, Pages 230-235

  Pan, Wei ^a   Yu, Jingjia ^b   Shi, Ruizheng ^a   Yan, Lei ^a   Yang, Tianlun ^a   Li, Yuanjian ^c   Zhang, Zhuohua ^b   Yu, Guolong ^a   Bai, Yongping ^a   Schuchman, Edward H ^d   He, Xingxuan ^d   Zhang, Guogang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

acute coronary syndromes; ceramide; matrix metalloproteinase; secretory acid sphingomyelinase; sphingomyelin; sphingomyelinase; tumor necrosis factor

Indexed keywords

CERAMIDE; GELATINASE A; GELATINASE B; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS; AGED; ANGINA PECTORIS; ATHEROSCLEROTIC PLAQUE; BLOOD; HEART INFARCTION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGIC MONITORING; PROCEDURES; TIME; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; CERAMIDES; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE, ATHEROSCLEROTIC; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84898539271     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000079     Document Type: Article

References (23)

1. Alewijnse AE, Peters SL. Sphingolipid signalling in the cardiovascular system: good, bad or both? Eur J Pharmacol 2008; 585:292-302.
2. Pavoine C, Pecker F. Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology. Cardiovasc Res 2009; 82:175-183.
3. Freynhofer MK, Tajsic M, Wojta J, Huber K. Biomarkers in acute coronary artery disease. Wien Med Wochenschr 2012; 162:489-498.
4. He X, Chen F, McGovern MM, Schuchman EH. A fluorescence-based, high-throughput sphingomyelin assay for the analysis of Niemann-Pick disease and other disorders of sphingomyelin metabolism. Anal Biochem 2002; 306:115-123.
5. He X, Chen F, Dagan A, Gatt S, Schuchman EH. A fluorescence-based, high-performance liquid chromatographic assay to determine acid sphingomyelinase activity and diagnose types A and B Niemann-Pick disease. Anal Biochem 2003; 314:116-120.
6. Liebisch G, Drobnik W, Reil M, Trumbach B, Arnecke R, Olgemoller B, et al. Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS/MS). J Lipid Res 1999; 40:1539-1546.
7. Yoo HH, Son J, Kim DH. Liquid chromatography-tandem mass spectrometric determination of ceramides and related lipid species in cellular extracts. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 843:327-333.
8. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science 1996; 274:1855-1859.
9. Schissel SL, Jiang X, Tweedie-Hardman J, Jeong T, Camejo EH, Najib J, et al. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J Biol Chem 1998; 273:2738-2746.
10. Portman OW, Alexander M. Metabolism of sphingolipids by normal and atherosclerotic aorta of squirrel monkeys. J Lipid Res 1970; 11:23-30.
11. Hoff HF, Morton RE. Lipoproteins containing apo B extracted from human aortas. Structure and function. Ann N Y Acad Sci 1985; 454:183-194.
12. Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007; 116:1832-1844.
13. Devlin CM, Leventhal AR, Kuriakose G, Schuchman EH,Williams KJ, Tabas I. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression. Arterioscler Thromb Vasc Biol 2008; 28:1723-1730.
14. Yeboah J, McNamara C, Jiang XC, Tabas I, Herrington DM, Burke GL, et al. Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30:628-633.
15. Schlitt A, Blankenberg S, Yan D, von Gizycki H, Buerke M,Werdan K, et al. Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease. Nutr Metab (Lond) 2006; 3:1-8.
16. de Mello VD, Lankinen M, Schwab U, Kolehmainen M, Lehto S, Seppanen-Laakso T, et al. Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia 2009; 52: 2612-2615.
17. Sattler KJ, Elbasan S, Keul P, Elter-Schulz M, Bode C, Graler MH, et al. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res Cardiol 2010; 105:821-832.
18. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 2013; 368:2004-2013.
19. Suzuki M. Acute coronary syndromes as auto-inflammatory disorders. Curr Pharm Des 2012; 18:4370-4384.
20. Jenkins RW, Canals D, Idkowiak-Baldys J, Simbari F, Roddy P, Perry DM, et al. Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation. J Biol Chem 2010; 285:35706-35718.
21. Auge N, Maupas-Schwalm F, Elbaz M, Thiers JC, Waysbort A, Itohara S, et al. Role for matrix metalloproteinase-2 in oxidized low-density lipoproteininduced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 2004; 110:571-578.
22. Kato Y, Ozawa S, Tsukuda M, Kubota E, Miyazaki K, St-Pierre Y, et al. Acidic extracellular pH increases calcium influx-triggered phospholipase D activity along with acidic sphingomyelinase activation to induce matrix metalloproteinase-9 expression in mouse metastatic melanoma. FEBS J 2007; 274:3171-3183.
23. Nah DY, Rhee MY. The inflammatory response and cardiac repair after myocardial infarction. Korean Circ J 2009; 39:393-398.